CUL9 and breast cancer: In breast cancer, miR-28-5p inhibited breast cancer cell migration through the regulation of WSB2 (Ma et al., 2020), whereas in colorectal cancer (CRC), reduced expression of CUL9 has been reported to inhibit CRC cell growth (Zhang L. et al., 2024).